News Daily News LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes Yael L. Maxwell September 14, 2020
News Conference News Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags L.A. McKeown September 10, 2020
News Conference News ESC 2020 Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism Caitlin E. Cox September 04, 2020
News Conference News ESC 2020 VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban L.A. McKeown September 03, 2020
News Conference News ESC 2020 Antihypertensives Cut CV Events Across BP Levels, Regardless of Prior CVD: BPLTTC Shelley Wood August 31, 2020
News Daily News Young Patients With Premature ASCVD Less Likely to Receive Statins, Aspirin Michael O'Riordan August 25, 2020
News Daily News Early Revascularization in NSTEMI Linked to Lower Mortality: AHRQ Analysis Michael O'Riordan August 20, 2020
News Daily News CV Prevention Meds Underused in Hispanic, Latinx PAD Patients L.A. McKeown August 12, 2020
News Daily News High-Sensitivity Troponin Hones ASCVD Risk in Secondary Prevention Michael O'Riordan August 11, 2020
News Daily News New Guidance on Use of Diabetes Drugs for CVD Risk Reduction: ACC Experts Michael O'Riordan August 06, 2020
News Daily News Cannabis Has No CV Benefits and Substantial Risks, Says AHA Statement Yael L. Maxwell August 06, 2020
News Daily News THALES: Ticagrelor Plus Aspirin Cuts Repeat Events After Stroke, TIA Todd Neale July 16, 2020
News Daily News Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects Michael O'Riordan July 13, 2020
News Daily News PAD Patients Undertreated With Statins Despite Elevated CV Risk L.A. McKeown July 13, 2020
News Daily News Inflammation Plays Into the ASCVD Risk Associated With Lp(a): ACCELERATE Michael O'Riordan July 08, 2020
News Daily News Statins Cut CV Risk but Don’t Boost Disability-Free Survival in Healthy Elderly Michael O'Riordan July 06, 2020
News Conference News EuroPCR 2020 No Survival Benefit With Revascularization in Stable CAD, Meta-analysis Confirms Michael O'Riordan June 26, 2020